Portal about health, health news.

Dirucotide Does Not Meet Primary Endpoint In Phase III MAESTRO-01 Trial In Secondary Progressive Multiple Sclerosis

Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp. (TSX: MS) announced that dirucotide did not meet the primary endpoint of delaying disease progression, as measured by the Expanded Disability Status Scale (EDSS), during the two-year MAESTRO-01 Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no statistically significant differences between dirucotide and placebo on the secondary endpoints of the study.

CNN Poll Finds Americans' Opinons Are Divided Regarding The President's Health Reform Push

Americans appear split over the president"s push for health care reform, a new CNN poll has found. "Fifty percent of those questioned in CNN/Opinion Research Corporation survey released Wednesday morning say they support the president"s plans, with 45 percent opposed. The results indicate a generational divide. ""Obama"s plan is most popular among younger Americans and least popular among senior citizens," says CNN Polling Director Keating Holland. "A majority of Americans over the age of 50 oppose Obama"s plan; a majority of those under 50 support it.""

News of the day

Success In Hospitalist-Run Short-Stay Units Driven By Availability Of Diagnostic Tests

The most important factors for a successful stay in hospital short-stay units (SSUs) are the types of diagnostic tests performed and whether or not specialty consultations are needed. When hospitalists staff these units, they can ensure that only patients who need readily accessible services are admitted. These are the findings of a study published in the Journal of Hospital Medicine.